Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dennis Kim, MD
Zafgen, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Davis
Sacramento, California, United States
- Ucsd: Rady Children'S Hospital
San Diego, California, United States
- Children'S Hospital of Colorado
Aurora, Colorado, United States
- University of Florida
Gainesville, Florida, United States
- Kansas University Medical Center
Kansas City, Kansas, United States
- National Institute of Child Health
Bethesda, Maryland, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Children'S Hospital and Clinics of Minnesota
Saint Paul, Minnesota, United States
- Saint Louis University
St Louis, Missouri, United States
- Winthrop University
Mineola, New York, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Vanderbilt University
Nashville, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Seattle Children'S Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2014
- Primary completion
- 31 Dec 2015
- Completion
- 31 Oct 2016
- Last update posted
- 26 Jan 2017
- Registered enrollment
- 108
- Registry id
- NCT02179151
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.